VolitionRx Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
VolitionRx Limited (VNRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 29.50 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-13
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2016-06-30 was 21.00K shares.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2016-03-31 was 5.00K shares.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2013-12-31 was 0.00 shares.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2013-09-30 was 10.00K shares.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2015 was 40.00K shares, a 33.33% decline from fiscal 2014.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2014 was 60.00K shares, a 100.00% increase from fiscal 2013.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2013 was 30.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 29.50K shares 10-Q · filed 2026-08-13 | |||
| 2016-06-30 | 21.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 26.00K shares 10-Q · filed 2016-08-11 | ||
| 2016-03-31 | 5.00K shares 10-Q · filed 2016-05-13 | |||
| 2015-12-31 | 40.00K shares 10-K · filed 2016-03-11 | |||
| 2014-12-31 | 60.00K shares 10-K · filed 2016-03-11 | |||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | 10.00K shares derived: sum of 2 quarters · filed 2015-03-18 | 30.00K shares 10-K · filed 2015-03-18 | |
| 2013-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | 30.00K shares 10-Q · filed 2013-10-31 | ||
| 2013-06-30 | 20.00K shares 10-Q · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |